Posted by Michael Wonder on 25 May 2020
SMC response to COVID-19
22 May 2020 - To prioritise and support the capacity of health and social care services, Healthcare Improvement Scotland and the Scottish Medicines Consortium have taken the decision to adapt its normal ways of working.
Consequently, SMC meetings and New Drugs Committees (NDC), have been suspended until further notice. Taking this step will release our committee members and staff to support work aligned with COVID-19 resilience. A core team will continue to assess the new medicine submissions in the system and work on urgent activities around COVID-19 as required.
The SMC cannot accept new submissions or resubmissions at the current time.
